The company is not selling any securities under this prospectus and will not receive any proceeds from the sale of its common stock by the selling stockholder.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT:
- Conduit Pharmaceuticals receives further patent approval for AZD1656
- Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update
- Conduit Pharmaceuticals announces new addition to autoimmune pipeline
- Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements
- Conduit Pharmaceuticals files $100M mixed securities shelf